TREATMENT OF STEROID-RESISTANT POSTTRANSPLANT NEPHROTIC SYNDROME WITH CYCLOPHOSPHAMIDE IN A CHILD WITH CONGENITAL NEPHROTIC SYNDROME

被引:12
作者
FLYNN, JT
SCHULMAN, SL
DECHADAREVIAN, JP
DUNN, SP
KAISER, BA
POLINSKY, MS
BALUARTE, HJ
机构
[1] Department of Pediatrics, St. Christopher's Hospital for Children, Temple University School of Medicine, Philadelphia, 19134-1095, Pennsylvania, Erie Avenue at Front Street
[2] Department of Anatomic Pathology, St. Christopher's Hospital for Children, Temple University School of Medicine, Philadelphia, Pennsylvania
[3] Department of General Surgery, St. Christopher's Hospital for Children, Temple University School of Medicine, Philadelphia, Pennsylvania
关键词
CONGENITAL NEPHROTIC SYNDROME; RENAL TRANSPLANT; CORTICOSTEROIDS; CYCLOPHOSPHAMIDE; POSTTRANSPLANT NEPHROTIC SYNDROME;
D O I
10.1007/BF00866503
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
A child with congenital nephrotic syndrome underwent renal transplantation, was treated for acute rejection, and then developed nephrotic syndrome and renal failure. He was felt to have minimal change disease on allograft biopsy, but failed to respond to therapy with corticosteroids. Cyclophosphamide was substituted for cyclosporine and rapidly induced a complete remission of his nephrotic syndrome. We feel that this case not only represents an important example of a useful therapeutic approach to the child with congenital nephrotic syndrome who develops nephrotic syndrome post transplantation, and also raises questions concerning the pathogenesis of congenital nephrotic syndrome.
引用
收藏
页码:553 / 555
页数:3
相关论文
共 12 条
[1]  
Hoyer J.R., Anderson C.E., Congenital nephrotic syndrome, Clin Perinatol, 8, pp. 333-346, (1981)
[2]  
Mahan J.D., Mauer S.M., Sibley R.K., Vernier R.L., Congenital nephrotic syndrome: evolution of medical management and results of renal transplantation, J Pediatr, 105, pp. 549-557, (1984)
[3]  
Hoyer J.R., Kjellstrand C.M., Simmons R.L., Najarian J.S., Mauer S.M., Buselmeier T.J., Michael A.F., Vernier R.L., Successful renal transplantation in 3 children with congenital nephrotic syndrome, Lancet, 1, pp. 1410-1412, (1973)
[4]  
Holmberg C., Jalanko H., Koskimies O., Leijala M., Salmela K., Eklund B., Wikstrom S., Ahonen J., Renal transplantation in children with congenital nephrotic syndrome of the Finnish type, Transplant Proc, 22, pp. 158-159, (1990)
[5]  
Sigstrom L., Hansson S., Jodal U., Long-term survival of a girl with congenital nephrotic syndrome and recurrence of proteinuria after transplantation (abstract), Pediatr Nephrol, 3, (1989)
[6]  
Lane P.H., Schnaper H.W., Vernier R.L., Bunchman T.E., Steroid-dependent nephrotic syndrome following renal transplantation for congenital nephrotic syndrome, Pediatr Nephrol, 5, pp. 300-303, (1991)
[7]  
Arbitol C., Zilleruelo G., Freudilch M., Strauss J., Quantification of proteinuria with urinary protein/creatinine ratios and random testing with dipsticks in nephrotic children, J Pediatr, 116, pp. 243-247, (1990)
[8]  
Steffensen G.K., Nielsen K.F., Nephrotic syndrome in the first three months of life, Child Nephrol Urol, 10, pp. 1-7, (1990)
[9]  
Mauer S.M., Hellerstein S., Cohn R.A., Sibley R.K., Vernier R.L., Recurrence of steroid-responsive nephrotic syndrome after renal transplantation, J Pediatr, 95, pp. 261-264, (1979)
[10]  
Feehally J., Beattie T.J., Brenchley P.E.C., Coupes B.M., Houston I.B., Mallick N.P., Postlewaite R.J., Modulation of cellular immune function by cyclophosphamide inchildren with minimal change nephropathy, N Engl J Med, 310, pp. 415-420, (1985)